CV Lattes
ORCID
Abstract
Osteoporosis is an osteometabolic disease, characterized by a reduction in bone mass in long bones and vertebrae, which occurs due to a decrease in estrogen levels, especially in postmenopausal women. Recently, a new drug based on an anti-sclerostin antibody (Scl-Ab) was approved for postmenopausal osteoporosis treatment. Its mechanism of action corresponds to an increase in the activity …